Open AccessImmune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre
Author(s) -
I. González-Mazón,
L. Sánchez-Bilbao,
J. L. Martín-Varillas,
Almudena GarcíaCastaño,
Marina Delgado-Ruiz,
Isabel Bernat Piña,
José L. Hernández,
Santos Castañeda,
Javier Llorca,
Miguel Á. González-Gay,
R. Blanco
Publication year - 2021
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/o5nvgv
Subject(s) - medicine , ipilimumab , nivolumab , atezolizumab , pembrolizumab , adverse effect , rheumatoid arthritis , lupus nephritis , rheumatology , kidney cancer , myositis , gastroenterology , cancer , immunology , immunotherapy , disease